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The incidence of melanoma is increasing and is projected 
to continue to do so (1). In Ireland, 20 people per 100,000 
of the population develop invasive melanoma every year 
and 159 die from it (2).
Despite improvements in early detection (3), the num-
ber of deep poor prognosis melanomas remains high (4). 
Older age, male sex (5), living alone and lower education 
level (6), have been identified as factors associated with 
thick melanomas. There has been much focus on the role 
of general practitioners in melanoma screening strategies. 
However, the role of non-dermatology hospital services 
in detecting melanoma has been poorly explored. The aim 
of this project was to determine if an opportunity exists 
for detection of melanoma in secondary care facilities.
MATERIAL AND METHODS
Ethical approval was obtained from the Cork Research Ethics 
Committee.
A retrospective case review was conducted at 5 hospitals across 
the region. The pathology database at Cork University Hospital 
(CUH), which processes histology samples from all 5 hospitals, 
was searched. The inclusion criteria were patients with a Cork/
Kerry address, diagnosed with primary cutaneous melanoma ≥ 1 
mm Breslow depth, between January 2013 and December 2014. 
Each clinical site was visited and hospital utilization data for each 
patient at each of the 5 clinical sites was collected.
There were 106 patients included in the study; 51 men (48%) and 
55 women (52%). The mean age was 63 years at time of diagnosis. 
RESULS
The median Breslow depth was 2.3 mm with a range from 
1.0 mm to 41 mm. Twenty-three (22%) were > 5 mm 
Breslow depth at time of diagnosis. Sixty-seven percent 
(n = 71) of patients were seen in secondary care in the 5 
years prior to their diagnosis of melanoma. There were 
a total of 901 healthcare interactions. The majority of 
these interactions were in the outpatient setting (57.5%). 
However, almost one third (31%) had an inpatient admis-
sion in the 5 years prior to diagnosis with a mean length 
of stay of 6 days. 
 Forty-five patients (42.5%) were seen in secondary 
care in the year prior to diagnosis. Results are illustrated 
in Fig. 1. There were a total of 214 healthcare interac-
tions. Thirty-five percent (n = 37) were seen in outpatient 
clinics and 10.4% (n = 11) had an inpatient admission. 
The median Breslow depth in this group was 2.5 mm. 
Forty percent (n = 18) of these patients had melanomas 
located on the head and neck.
Head and neck was the most common anatomical 
location (n =32) followed by lower limb (n =30), upper 
limb (n =22) and trunk (n =22). Of the 32 patients with 
a head and neck melanoma, 18 (56%) had been seen in 
secondary care in the year prior to their diagnosis.
In terms of histological subtype, the majority were 
superficial spreading type (n =48) followed by nodular 
(n =30), lentigo maligna (n =18), other (n =6) and acral 
lentiginous (n =4). 
The specialties with the most patient interactions in 
the year prior to diagnosis were ophthalmology, ortho-
paedics, and emergency medicine.
DISCUSSION
This study has identified that patients with thick me-
lanomas are being seen in hospital in the year prior to 
their diagnosis. Research on the use of health services 
in the year prior to diagnosis of melanoma have found 
similar results (7, 8), but these studies did not isolate for 
interactions in secondary care. Outpatient visits contri-
buted to the majority of healthcare interactions in our 
study. While there may be limited opportunity for full 
skin examination in an outpatient setting, studies have 
shown that even opportunistic partial skin examinations 
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Fig. 1. Secondary care interactions in the year prior to melanoma 
diagnosis. (ED=Emergency Department).
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have been effective in detecting melanoma at a thinner 
stage (9).
The majority of melanomas in our study were located 
on the head and neck region and would therefore have 
been readily identifiable without the need for full skin 
examination. 
While it is impossible to say how long a melanoma 
may have been present prior to diagnosis, the majority 
of melanomas in this study were superficial spreading 
subtype and a significant number were lentigo maligna 
subtype, suggesting that these lesions had likely been 
present for a significant period of time prior to diagnosis.
Significant opportunity exists to improve early detec-
tion of melanoma by healthcare providers in secondary 
care. Strategies to promote this would include greater 
emphasis on melanoma detection in medical student 
curriculum, and continuous professional development 
modules on opportunistic skin cancer detection for 
healthcare providers. Dermatologists should work with 
these groups to promote further education and awareness. 
A larger study is needed to explore this issue further 
in other countries and populations.
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